Your browser is no longer supported. Please, upgrade your browser.
Settings
GALE Galena Biopharma, Inc. daily Stock Chart
GALE [NASD]
Galena Biopharma, Inc.
Index- P/E- EPS (ttm)-2.32 Insider Own0.20% Shs Outstand10.49M Perf Week-20.35%
Market Cap28.32M Forward P/E- EPS next Y-2.80 Insider Trans-85.81% Shs Float10.49M Perf Month-25.00%
Income-20.00M PEG- EPS next Q-0.65 Inst Own22.10% Short Float11.04% Perf Quarter-66.25%
Sales- P/S- EPS this Y-5.90% Inst Trans56.93% Short Ratio0.41 Perf Half Y-93.32%
Book/sh2.29 P/B1.18 EPS next Y0.40% ROA-51.10% Target Price22.67 Perf Year-90.88%
Cash/sh2.34 P/C1.16 EPS next 5Y- ROE-214.90% 52W Range2.61 - 49.80 Perf YTD-90.82%
Dividend- P/FCF- EPS past 5Y17.90% ROI- 52W High-94.58% Beta2.96
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low3.45% ATR0.45
Employees22 Current Ratio1.00 Sales Q/Q- Oper. Margin- RSI (14)29.27 Volatility11.89% 13.63%
OptionableYes Debt/Eq0.99 EPS Q/Q47.10% Profit Margin- Rel Volume0.13 Prev Close2.83
ShortableYes LT Debt/Eq0.00 EarningsNov 09 AMC Payout- Avg Volume2.79M Price2.70
Recom2.30 SMA20-23.33% SMA50-44.68% SMA200-83.97% Volume363,562 Change-4.59%
Dec-02-16Reiterated Maxim Group Buy $1 → $4
Aug-10-16Reiterated Maxim Group Buy $2 → $1
Jul-22-16Reiterated FBR Capital Outperform $5 → $2
Jul-11-16Reiterated Maxim Group Buy $4 → $2
Jun-29-16Downgrade Raymond James Outperform → Mkt Perform
Dec-22-15Reiterated Maxim Group Buy $7 → $4
Dec-08-15Upgrade Cantor Fitzgerald Sell → Hold
Nov-12-15Upgrade Oppenheimer Perform → Outperform $4
Nov-10-15Reiterated ROTH Capital Buy $8 → $6
Sep-09-15Initiated Raymond James Outperform
Mar-09-15Reiterated Needham Buy $7 → $4
Nov-20-14Reiterated MLV & Co Buy $3 → $5
Aug-22-14Reiterated MLV & Co Buy $5 → $3.50
Aug-12-14Reiterated Needham Buy $9 → $7
Feb-03-14Reiterated Noble Financial Buy $4 → $6
Jan-21-14Reiterated Maxim Group Buy $9 → $11
Jan-08-14Reiterated Maxim Group Buy $6 → $9
Nov-26-13Initiated Oppenheimer Outperform $6
Mar-25-13Initiated Needham Buy $3.50
Nov-28-12Initiated Aegis Capital Buy $6
Dec-05-16 02:39PM  Why You Should (and Shouldn't) Buy Galena Biopharma, Inc. at Motley Fool
08:30AM  Galena Biopharma Inc. Presentation Now Available for On-Demand Viewing PR Newswire
08:30AM  Galena Biopharma Inc. Presentation Now Available for On-Demand Viewing CNW Group
Dec-02-16 08:07AM  New Strong Buy Stocks for December 2nd
Nov-30-16 01:31PM  Galena Biopharma to Present Two Posters at the San Antonio Breast Cancer Symposium GlobeNewswire
Nov-29-16 09:30AM  Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma -7.96%
Nov-25-16 09:01AM  Why BioScrip (BIOS) Could Be Positioned for a Slump
Nov-23-16 04:44PM  Galena Biopharma, Inc. in 3 Charts at Motley Fool
08:30AM  Public Company Executives to Present Online to Investors on December 1 PR Newswire
08:30AM  Public Company Executives to Present Online to Investors on December 1 CNW Group
Nov-22-16 08:30AM  Galena Biopharma Inc. to Webcast, Live, at VirtualInvestorConferences.com December 1 PR Newswire -9.21%
08:30AM  Galena Biopharma Inc. to Webcast, Live, at VirtualInvestorConferences.com December 1 CNW Group
Nov-18-16 08:50AM  New Strong Buy Stocks for November 18th +6.55%
Nov-17-16 01:04PM  GALENA BIOPHARMA, INC. Financials
Nov-16-16 08:52AM  New Strong Buy Stocks for November 16th
Nov-15-16 03:48PM  Biotech Movers And Shakers: Corbus Pharmaceuticals Holdings Inc (CRBP) And Galena Biopharma Inc (GALE) at Insider Monkey
Nov-14-16 07:05AM  Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the Society for Immunotherapy of Cancer Conference 2016 GlobeNewswire -15.71%
04:50AM  Galena Declares 1-for-20 Reverse Split (GALE) at Investopedia
Nov-11-16 09:30AM  Galena Biopharma 3Q Loss $6.9M or 3c/Share (GALE) at Investopedia
Nov-09-16 06:19PM  Galena Biopharma reports 3Q loss +5.56%
04:52PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, F
04:10PM  Galena Biopharma Reports Third Quarter 2016 Financial Results and Provides a Corporate Update GlobeNewswire
07:07AM  Q3 2016 Galena Biopharma Inc Earnings Release - After Market Close
Nov-03-16 04:31PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers -5.26%
07:05AM  Galena Biopharma Appoints Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer GlobeNewswire
Nov-02-16 03:13PM  Biotech Movers This Week: Galena Biopharma Inc (GALE) And Oculus Innovative Sciences, Inc. (OCLS) at Insider Monkey
Oct-31-16 04:33PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders -8.00%
04:30PM  Galena Biopharma Announces Reverse Stock Split GlobeNewswire
11:08AM  Research Reports on Biotech Equities -- Mast Therapeutics, Array BioPharma, Galena Biopharma, and Clovis Oncology PR Newswire
Oct-26-16 05:18PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -6.90%
09:30AM  Zacks.com featured highlights: Galena Biopharma, Check Point Software Technologies, Sequans Communications S.A., CubeSmart and Great Panther Silver
07:05AM  Galena Biopharma to Report Third Quarter 2016 Financial Results and Provide a Corporate Update on Wednesday, November 9, 2016 GlobeNewswire
Oct-25-16 06:41AM  5 Top-Ranked Stocks with Rising P/E for Blowout Gains
Oct-20-16 07:05AM  Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the American College of Surgeons Clinical Congress 2016 GlobeNewswire +14.81%
Oct-10-16 07:05AM  Galena Biopharma to Present NeuVax (nelipepimut-S) plus Trastuzumab Interim Safety Data at the European Society for Medical Oncology (ESMO) 2016 Congress GlobeNewswire
Oct-06-16 05:28PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhib
08:35AM  7 Key FDA Decisions and Clinical Trial Results Coming in Q4 at 24/7 Wall St.
Sep-29-16 07:05AM  Galena Biopharma to Present NeuVax (nelipepimut-S) Interim Safety Data at the European Society for Medical Oncology (ESMO) 2016 Congress GlobeNewswire -5.71%
Sep-27-16 04:05PM  Galena Biopharma Presents GALE-301 Folate Binding Protein Expression Data at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference GlobeNewswire
Sep-20-16 07:05AM  Galena Biopharma to Present at the Sachs Associates 16th Annual Biotech in Europe Forum GlobeNewswire +18.75%
Sep-19-16 03:35PM  Galena Wins Exclusive Japanese Patent (GALE) at Investopedia
Sep-14-16 07:05AM  Galena Biopharma to Present at the 2016 Aegis Growth Conference GlobeNewswire -5.71%
Sep-13-16 09:50AM  Galena Biopharma Presents Preclinical NeuVax (nelipepimut-S) Data in Ovarian and Pancreatic Cancer at the Progress in Vaccination Against Cancer (PIVAC) Conference GlobeNewswire
Sep-12-16 07:05AM  Galena Biopharma Expands GALE-401 Intellectual Property Protection with Patent Issuance in Japan GlobeNewswire -7.89%
Sep-09-16 07:05AM  Galena Biopharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference GlobeNewswire -5.00%
Sep-08-16 04:53PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Aug-23-16 10:28AM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Right
Aug-22-16 04:50PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Financial Statements and Exhibits
Aug-19-16 09:34AM  Galena Biopharma (GALE) is Oversold: Can It Recover? +7.50%
Aug-16-16 04:43PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan
Aug-12-16 04:09PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Aug-09-16 10:27PM  Edited Transcript of GALE earnings conference call or presentation 9-Aug-16 9:00pm GMT -6.12%
05:51PM  Galena Biopharma beats 2Q profit forecasts
05:00PM  GALENA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report
04:51PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Prin
04:05PM  Galena Biopharma Reports Second Quarter 2016 Financial Results and Provides a Corporate Update GlobeNewswire
07:07AM  Q2 2016 Galena Biopharma Inc Earnings Release - After Market Close
Jul-26-16 07:05AM  Galena Biopharma to Report Second Quarter 2016 Financial Results and Provide a Corporate Update on Tuesday, August 9, 2016 GlobeNewswire
Jul-20-16 08:55AM  Galena Biopharma (GALE) is Oversold: Can It Recover? +28.95%
Jul-18-16 05:18PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jul-13-16 04:35PM  Galena Biopharma Announces Closing of Registered Direct Offering GlobeNewswire
Jul-12-16 06:08AM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities -6.52%
Jul-08-16 07:36AM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Fina -9.80%
07:35AM  Galena Biopharma to Host Webcast and Conference Call Today GlobeNewswire
07:05AM  Galena Biopharma Announces Pricing of Registered Direct Offering GlobeNewswire
Jul-03-16 09:35AM  4 Companies That Destroyed Shareholders Despite a Brexit Recovery at 24/7 Wall St.
Jun-30-16 08:17AM  Galena (GALE) Stock Falls on Discontinuation of NeuVax Study +34.29%
07:14AM  Why These Five Stocks Are in Spotlight at Insider Monkey
Jun-29-16 02:50PM  2 Big-Volume Stocks to Add to Your Buy List -- Plus 5 Risky Ones to Avoid -82.76%
01:21PM  Is Galena Dead in the Water After This Failed Trial? at 24/7 Wall St.
10:56AM  Why Galena Biopharma Inc. Is Being Obliterated Today at Motley Fool
10:39AM  Galena Biopharma downgraded by Raymond James
08:39AM  Galena Biopharma Plunges 80% Amid Discontinued NeuVax Phase 3, PRESENT Interim Analysis
08:24AM  Galena Craters on Breast Cancer Vaccine Study Failure
07:07AM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Financial Statements and Exhibits
07:05AM  Galena Biopharma Discontinues NeuVax (nelipepimut-S) Phase 3, PRESENT Interim Analysis based on Independent Data Monitoring Committee Recommendation GlobeNewswire
Jun-28-16 08:24AM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Other Events
Jun-24-16 01:24PM  The Brexit Vote Is Crushing These 3 Clinical-Stage Biotech Stocks at Motley Fool
Jun-23-16 09:10AM  Galena Biopharma (GALE) is Overbought: Is A Drop Coming? -5.29%
Jun-21-16 11:19AM  Heres Why These Five Stocks Are Gaining Ground on Tuesday at Insider Monkey
Jun-13-16 07:05AM  Galena Biopharma Presents GALE-401 Combined Safety Data at the European Hematology Association 21st Congress GlobeNewswire
Jun-10-16 02:47PM  Galena Biopharma Receives Two Orphan Drug Designations for GALE-301 and GALE-301/GALE-302 GlobeNewswire +5.05%
Jun-07-16 07:12AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Galena Biopharma, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Jun-06-16 02:00PM  Galena Biopharma Presents GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 2016 GlobeNewswire
Jun-04-16 06:41AM  These 2 Catalysts Helped Push Galena Biopharma, Inc. 31% Higher in May at Motley Fool
Jun-02-16 01:49PM  10 Potentially Game-Changing Cancer Immunotherapies You Should Be Following at Motley Fool
09:19AM  Here is Proof that Small Cap Growth Is Not Slowing
08:15AM  Galena Biopharma (GALE) in Focus: Stock Moves Up 19.3%
Jun-01-16 03:10PM  Why Galena Biopharma, Whole Foods, Ocean Power Tech, Actinium Pharma & Shopify Spiked Today at Insider Monkey +19.34%
02:23PM  Why Galena Biopharma, Inc. Was on the Fast Track to a Higher Stock Price Today at Motley Fool
07:05AM  Galena Biopharma Receives Fast Track Designation for NeuVax (nelipepimut-S) PRESENT Clinical Trial GlobeNewswire
May-24-16 07:05AM  Galena Biopharma to Present at the Sachs Associates 2nd Annual Immuno-Oncology BD&L and Investment Forum GlobeNewswire
May-19-16 12:15PM  Galena Biopharma to Present GALE-401 Combined Safety Data at the European Hematology Association 21st Congress GlobeNewswire
May-18-16 05:45PM  Galena Biopharma to Present the GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 2016 GlobeNewswire +12.98%
May-11-16 02:15AM  Edited Transcript of GALE earnings conference call or presentation 10-May-16 9:00pm GMT -7.25%
May-10-16 05:30PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, F
04:56PM  Galena Biopharma reports 1Q loss
04:10PM  Galena Biopharma Reports First Quarter 2016 Financial Results and Provides a Corporate Update GlobeNewswire
07:07AM  Q1 2016 Galena Biopharma Inc Earnings Release - After Market Close
Apr-27-16 07:05AM  Galena Biopharma to Report First Quarter 2016 Financial Results and Provide a Corporate Update on Tuesday, May 10, 2016 GlobeNewswire
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs. The company's lead product candidate, NeuVax (nelipepimut-S), is in Phase III clinical trials for the prevention of recurrence in early- stage and node-positive breast cancer with low to intermediate human epidermal growth factor receptor (HER2) expression; Phase IIb clinical trials in combination with Herceptin for HER2 1+/2+ node-positive and high-risk node-negative breast cancer treatment; and Phase II clinical trials in combination with trastuzumab for node positive and negative HER2 IHC 3+ patients. It also develops GALE-301 (folate binding protein), which is in Phase IIa clinical trials for the prevention of recurrence in patients with ovarian and endometrial cancers; GALE-302, a version of the E39 peptide that is in Phase 1b clinical trial for investigating a novel vaccination series; and GALE-401 (anagrelide controlled release), which is in a Phase II clinical trial for the treatment of patients with myeloproliferative neoplasms to lower elevated platelet levels. Galena Biopharma, Inc. has strategic development and commercialization partnership with Dr. Reddy's Laboratories Ltd. for NeuVax in breast and gastric cancers. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011. Galena Biopharma, Inc. was founded in 2003 and is based in San Ramon, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dunlap RyanFormer Chief Financial OfficerJun 01Option Exercise1.79126,875227,394145,577Jun 07 06:36 PM
Dunlap RyanFormer Chief Financial OfficerJun 01Sale2.18126,875276,58818,702Jun 07 06:36 PM